Description
Estrogen receptors (ERs) are primary targets for chemoprevention and endocrine therapy of breast cancer (BC) and provide prognostic and predictive information concerning tumor response to endocrine therapies. Expression of ERβ reduces cancer cell proliferation and tumor growth, pointing to an anti-proliferative action of this transcription factor and its positive prognostic value. Moreover, it has emerged that unliganded ERβ exhibits an active role in constitutive regulation of target genes transcription. Indeed, gene expression profiling of hormone-deprived human BC cells expressing ERβ revealed a great impact of this ER subtype in the modulation of gene expression in absence of hormonal ligands. Starting from this observation, and to identify key nuclear factors acting in concert with ligand-free ERβ, Tandem Affinity Purification (TAP) coupled to mass spectrometry (MS) was applied to isolate nuclear protein complexes associated to unliganded ERβ in BC cells. Among the >300 proteins identified, we focused our attention on the functional significance of a complex comprising ERβ and AGO2, since this argonaute protein has been implicated in key biological processes in the cell nucleus. ERβ association with AGO2 and other known AGO2 interacting proteins was confirmed by co-immunoprecipitation in MCF-7 cells expressing tagged ERβ. ChIP-Seq allowed the identification of a number of ERβ- and AGO-binding sites to breast cancer cells genome, while AGO2 knock down resulted in significant changes in transcription rate and co-transcriptional mRNA splicing of a group of genes, comprising in particular a significant number of those modulated by unliganded ERβ. In conclusion, these experimental evidences suggest that AGO2 is a functional partner of ERβ involved in hormone-independent gene regulation in BC cells. Additional data related to this study has also been deposited in ArrayExpress under accession number E-MTAB-4639 (http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4639)